Skip to content

Study of the usefulness of endoscopic resection for gastric submucosal tumors

Study of the usefulness of endoscopic resection for gastric submucosal tumors - Study of the usefulness of ER for gastric SMT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045574
Enrollment
20
Registered
2021-09-30
Start date
2021-09-30
Completion date
Unknown
Last updated
2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric submucosal tumor

Interventions

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: 1) Patients with psychosis or psychiatric symptoms that would make participation in the study difficult. 2) Complications of poorly controlled heart failure 3) Respiratory disease requiring continuous oxygen administration. 4) Patients with end-stage renal disease. 5) Patients with uncompensated liver cirrhosis or liver failure 6) Patients with an apparent bleeding tendency 7) Patients on antithrombotic and anticoagulant medication who are unable to follow the standard recommendations for high-risk gastrointestinal endoscopy for bleeding in the Japanese Society of Gastrointestinal Endoscopy's "Guidelines for Gastrointestinal Endoscopy for Patients on Antithrombotic Drugs" and "Guidelines for Gastrointestinal Endoscopy for Patients on Antithrombotic Drugs--Addendum on Anticoagulants Including Direct (New) Oral Anticoagulants (DOAC) 2017". 8) Patients who are judged by the physician to be unsuitable for this study.

Design outcomes

Primary

MeasureTime frame
Endoscopic en bloc resection rate

Secondary

MeasureTime frame
Histological complete resection rate, endoscopic procedure complete resection rate, adverse event, procedure time.

Countries

Japan

Contacts

Public ContactNoriko Matsuura

Keio University, school of medicine Cancer center, division of research and development for minimal invasive treatment

matsuura-no@keio.jp03-5363-3437

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026